Lenalidomide, a thalidomide derivative, shows promise in various applications.
作者信息
Oestreicher Pamela
出版信息
ONS Connect. 2007 Aug;22(8):22-3.
PMID:17824579
Abstract
摘要
相似文献
1
Lenalidomide, a thalidomide derivative, shows promise in various applications.
ONS Connect. 2007 Aug;22(8):22-3.
2
The clinical utility of lenalidomide in multiple myeloma and myelodysplastic syndromes.
J Oncol Pharm Pract. 2010 Dec;16(4):223-32. doi: 10.1177/1078155209351967. Epub 2009 Nov 12.
3
Lenalidomide and its role in the management of multiple myeloma.
Expert Rev Anticancer Ther. 2008 Jun;8(6):865-74. doi: 10.1586/14737140.8.6.865.
4
Role of lenalidomide in the treatment of multiple myeloma and myelodysplastic syndrome.
Ann Pharmacother. 2006 Feb;40(2):286-9. doi: 10.1345/aph.1G170. Epub 2006 Jan 10.
5
Lenalidomide: a new agent for patients with relapsed or refractory multiple myeloma.
Clin J Oncol Nurs. 2007 Aug;11(4):569-74. doi: 10.1188/07.CJON.569-574.
6
A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.
Clin Adv Hematol Oncol. 2007 Oct;5(10 Suppl 15):7-19, quiz 21-2.
7
Lenalidomide: new drug. Myeloma: many questions remain unanswered.
Prescrire Int. 2008 Dec;17(98):230-2.
8
Lenalidomide.
Recent Results Cancer Res. 2014;201:347-57. doi: 10.1007/978-3-642-54490-3_21.
9
Neutrophilic dermatosis complicating lenalidomide therapy.
J Am Acad Dermatol. 2009 Oct;61(4):709-10. doi: 10.1016/j.jaad.2008.12.011. Epub 2009 Jul 3.
10
Advances in the treatment of MDS, multiple myeloma, and CLL.
ONS Connect. 2007;22(8 Suppl):55-6.
Zotero 插件